Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

Could yeast and humans be any more different? Going by looks alone, probably not. But peering into our genomes reveals ...

New study provides insights about autoimmune diseases involving anti-Ro/SSA and anti-La/SSB autoantibodies, and the therapeutic application of RNase treatment. RNases have been proposed as a treatment ...

Our understanding of RNA interference has been enhanced by new data concerning RNase III molecules. The role of Dicer has previously been established in RNAi as the originator of 22-mers ...

Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these diseases. RNase ...

In a recent study published in Science, researchers assessed the inborn abnormalities of 2′-5′-oligoadenylate synthetase (OAS)-ribonuclease L (RNASEL) noted in coronavirus disease 2019 ...

Endoribonuclease E (RNase E) is a regular of global gene expression in Escherichia coli and is the best studied member of the RNase E/G ribonuclease family. Homologues are present in other bacteria ...

Scientists have deciphered how two enzymes, RNase H2 and RNase H1, are coordinated to remove RNA-DNA hybrid structures from chromosomes. Two research teams led by Professors Brian Luke and Helle ...

Osaka, Japan – Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these ...

Scientists have developed new technology to detect the activity of RNase H, a RNA degrading enzyme. The team used highly efficient signal amplification reaction termed catalytic hairpin assembly (CHA) ...

PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available ...